Novartis Investigative Site

Zhuzhou, Hunan 412000

0 studies enrolling now · 2 studies all time

What they study most

Autoimmunity, Inflammation, Systemic Lupus Erythematosus

Studies at this site

• Secukinumab Open Label Roll-over Extension Protocol — Recruiting now
• Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1) — Running, not enrolling